methylprednisolone and Hospital Acquired Pneumonia

methylprednisolone has been researched along with Hospital Acquired Pneumonia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Grewal, P; Hotelling, J; Jacob, R; Kalogeropoulos, AP; Mansour, M; Marcos, LA; Mojahedi, A; Papamanoli, A; Predun, W; Skopicki, HA; Yoo, J	1

Other Studies

1 other study(ies) available for methylprednisolone and Hospital Acquired Pneumonia

Article	Year
High-dose methylprednisolone in nonintubated patients with severe COVID-19 pneumonia. European journal of clinical investigation, 2021, Volume: 51, Issue:2 Topics: Aged; Bacteremia; Continuous Positive Airway Pressure; COVID-19; COVID-19 Drug Treatment; Female; Gastrointestinal Hemorrhage; Glucocorticoids; Healthcare-Associated Pneumonia; Humans; Intensive Care Units; Length of Stay; Male; Methylprednisolone; Middle Aged; Oxygen Inhalation Therapy; Pneumonia, Ventilator-Associated; Proportional Hazards Models; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Treatment Outcome	2021

Article

Year

High-dose methylprednisolone in nonintubated patients with severe COVID-19 pneumonia.

European journal of clinical investigation, 2021, Volume: 51, Issue:2

Topics: Aged; Bacteremia; Continuous Positive Airway Pressure; COVID-19; COVID-19 Drug Treatment; Female; Gastrointestinal Hemorrhage; Glucocorticoids; Healthcare-Associated Pneumonia; Humans; Intensive Care Units; Length of Stay; Male; Methylprednisolone; Middle Aged; Oxygen Inhalation Therapy; Pneumonia, Ventilator-Associated; Proportional Hazards Models; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Treatment Outcome

2021